The Foundation is providing £68,000 in support.
Irene Roquero
GSK provides expertise and know-how in high throughput screening and later compound profilling, as well as access to key facilities to set-up and perform this work. GSK is also providing information about the parasitological and toxicological profile of the promising molecules identified.